Follow The Filings

Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

  • $21.7B
  • 77 holdings
  • 2026 Q2
  • +23.6% QoQ
  • Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ
2021 Q3: $19.7B 2021 Q3: $19.7B
Q3 2021
2021 Q4: $18.7B, −5.1% QoQ 2021 Q4: $18.7B, −5.1% QoQ
Q4
2022 Q1: $18.8B, +0.4% QoQ 2022 Q1: $18.8B, +0.4% QoQ
Q1 2022
2022 Q2: $16.3B, −13.7% QoQ 2022 Q2: $16.3B, −13.7% QoQ
Q2
2022 Q3: $16.8B, +3.5% QoQ 2022 Q3: $16.8B, +3.5% QoQ
Q3
2022 Q4: $15.3B, −9.3% QoQ 2022 Q4: $15.3B, −9.3% QoQ
Q4
2023 Q1: $17.7B, +15.8% QoQ 2023 Q1: $17.7B, +15.8% QoQ
Q1 2023
2023 Q2: $17.9B, +1.3% QoQ 2023 Q2: $17.9B, +1.3% QoQ
Q2
2023 Q3: $20B, +11.5% QoQ 2023 Q3: $20B, +11.5% QoQ
Q3
2023 Q4: $20.1B, +1.0% QoQ 2023 Q4: $20.1B, +1.0% QoQ
Q4
2024 Q1: $22.1B, +9.8% QoQ 2024 Q1: $22.1B, +9.8% QoQ
Q1 2024
2024 Q2: $21.2B, −4.2% QoQ 2024 Q2: $21.2B, −4.2% QoQ
Q2
2024 Q3: $20.4B, −3.6% QoQ 2024 Q3: $20.4B, −3.6% QoQ
Q3
2024 Q4: $19.7B, −3.5% QoQ 2024 Q4: $19.7B, −3.5% QoQ
Q4
2025 Q1: $17.9B, −9.0% QoQ 2025 Q1: $17.9B, −9.0% QoQ
Q1 2025
2025 Q2: $23.2B, +29.2% QoQ 2025 Q2: $23.2B, +29.2% QoQ
Q2
2025 Q3: $24.4B, +5.4% QoQ 2025 Q3: $24.4B, +5.4% QoQ
Q3
2025 Q4: $21.2B, −13.2% QoQ 2025 Q4: $21.2B, −13.2% QoQ
Q4
2026 Q1: $17.5B, −17.2% QoQ 2026 Q1: $17.5B, −17.2% QoQ
Q1 2026
2026 Q2: $21.7B, +23.6% QoQ 2026 Q2: $21.7B, +23.6% QoQ
Q2

Book

2025 Q3 2025 Q2, filed 14 Nov, long equity only

MSFT, Microsoft 4.06%, was 3.75% Add +9.5% 1,913,135 $517.95 $991M +165,300 +$122M
AON, Aon 3.33%, was 3.06% Add +14.7% 2,278,017 $356.58 $812M +291,600 +$104M
EXEL, Exelixis 3.30%, was 3.05% Add +21.6% 19,501,500 $41.30 $805M +3,466,000 +$99M
AMZN, Amazon 3.15%, was 2.87% Add +15.5% 3,505,700 $219.57 $770M +471,100 +$104M
NTRA, Natera 2.80%, was 3.51% Reduce −11.8% 4,253,452 $160.97 $685M −568,357 −$130M
RVMD, Revolution Medicines 2.80%, was 2.27% Add +2.1% 14,625,692 $46.70 $683M +300,000 +$156M
UNH, UnitedHealth Group 2.67%, was 2.18% Add +16.6% 1,886,500 $345.30 $651M +269,200 +$147M
TMO, Thermo Fisher Scientific 2.50% Reduce −9.0% 1,258,241 $485.02 $610M −125,000 +$49M
HIMS, Hims & Hers Health 2.50%, was 1.77% Add +30.8% 10,746,852 $56.72 $610M +2,533,271 +$200M
DIS, Disney 2.44% Add +6.7% 5,198,968 $114.50 $595M +324,700 −$9.2M
CRM, Salesforce 2.39% Add +16.7% 2,462,310 $237.00 $584M +353,200 +$8.4M
ADSK, Autodesk 2.16%, was 2.33% Reduce −4.7% 1,662,852 $317.67 $528M −81,800 −$12M
BSX, Boston Scientific 1.90%, was 1.84% Add +19.2% 4,746,557 $97.63 $463M +765,500 +$36M
GBTC, iShares Bitcoin Trust ETF 1.86% Reduce −0.4% 6,992,700 $65.00 $455M −27,350 +$25M
WAB, Wabtec 1.81%, was 1.18% Add +68.6% 2,205,098 $200.47 $442M +896,900 +$168M
BBIO, Bridgebio 1.74%, was 1.47% Add +3.7% 8,192,000 $51.94 $425M +292,000 +$84M
PTGX, Protagonist Therapeutics 1.68%, was 1.47% Add +0.4% 6,196,006 $66.43 $412M +24,000 +$70M
TRU, Transunion 1.62%, was 2.05% Reduce −12.4% 4,732,075 $83.78 $396M −672,500 −$79M
ARMK, Aramark 1.41%, was 2.33% Reduce −30.3% 8,996,202 $38.40 $345M −3,903,499 −$195M
INTU, Intuit 1.36%, was 1.82% Reduce −9.1% 488,088 $682.91 $333M −48,570 −$89M
K, Kellanova 1.32% New 3,943,853 $82.02 $323M +3,943,853 +$323M
NDAQ, Nasdaq 1.31%, was 1.58% Reduce −11.3% 3,623,043 $88.45 $320M −460,700 −$45M
ADI, Analog Devices 1.31% Add +2.1% 1,299,500 $245.70 $319M +27,300 +$16M
SCHW, Charles Schwab 1.27%, was 1.56% Reduce −17.9% 3,251,657 $95.47 $310M −707,400 −$51M
NYT, New York Times 1.17%, was 1.35% Reduce −11.1% 4,985,745 $57.40 $286M −623,801 −$28M
GOOG, Alphabet 1.12%, was 1.35% Reduce −36.4% 1,120,940 $243.55 $273M −640,900 −$40M
CBRE, CBRE Group 1.04%, was 1.28% Reduce −23.5% 1,616,038 $157.56 $255M −497,100 −$41M
MCK, McKesson 1.03%, was 0.99% Add +4.0% 327,100 $772.54 $253M +12,500 +$22M
BEAM, Beam Therapeutics 1.00%, was 0.73% Add +0.5% 10,063,111 $24.27 $244M +50,000 +$74M
CRNX 0.98%, was 0.58% Add +24.2% 5,770,098 $41.65 $240M +1,124,000 +$107M
ETHA, iShares Ethereum Trust 0.96% New 7,450,730 $31.51 $235M +7,450,730 +$235M
AGIO, Agios Pharmaceuticals 0.95%, was 0.83% Add +0.2% 5,781,066 $40.14 $232M +13,600 +$40M
V, Visa 0.84%, was 0.47% Add +94.2% 599,810 $341.38 $205M +291,000 +$95M
LQDA, Liquidia 0.80%, was 0.23% Add +102.1% 8,565,638 $22.74 $195M +4,326,876 +$142M
NSC, Norfolk Southern 0.76% New 615,000 $300.41 $185M +615,000 +$185M
LNTH, Lantheus 0.73%, was 2.37% Reduce −48.3% 3,477,227 $51.29 $178M −3,245,000 −$372M
IQV, IQVIA 0.73%, was 2.62% Reduce −75.6% 938,551 $189.94 $178M −2,912,800 −$429M
WWD, Woodward 0.64%, was 0.97% Reduce −32.0% 621,973 $252.71 $157M −292,700 −$67M
MA, Mastercard 0.50%, was 0.37% Add +40.6% 213,771 $568.81 $122M +61,700 +$36M
CNTA, Centessa Pharmaceuticals 0.43% Reduce −4.4% 4,331,318 $24.25 $105M −198,000 +$46M
TEVA, Teva Pharmaceutical Industries 0.41% New 4,997,000 $20.20 $101M +4,997,000 +$101M
TNGX, Tango Therapeutics 0.37%, was 0.20% Add +17.5% 10,757,000 $8.40 $90M +1,600,000 +$43M
BBNX, Beta Bionics 0.35%, was 0.26% Add +2.6% 4,313,920 $19.87 $86M +110,000 +$25M
THC, Tenet Healthcare 0.34%, was 0.40% Reduce −21.7% 414,000 $203.04 $84M −115,000 −$9M
GRAL, Grail 0.33%, was 0.11% Add +168.7% 1,349,000 $59.13 $80M +847,000 +$54M
EHC, Encompass Health 0.30%, was 0.37% Reduce −19.4% 571,000 $127.02 $73M −137,000 −$14M
OSCR, Oscar Health 0.28%, was 0.14% Add +146.5% 3,639,000 $18.93 $69M +2,163,000 +$37M
ABVX, Abivax 0.28% New 805,000 $84.90 $68M +805,000 +$68M
Mara 0.27%, was 0.06% Add +338.3% 3,660,000 $18.26 $67M +2,825,000 +$54M
MLYS, Mineralys Therapeutics 0.26% New 1,673,053 $37.92 $63M +1,673,053 +$63M

Showing top 50 of 126 by value

Exits / last held

Gone since 2025 Q2, shown at their last reported size.

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
SPY, SPDR S&P 500 ETF Trust 14.66% Exit 0 $617.85 $3.4B −5,500,000 −$3.4B
Hess 3.47% Exit 0 $138.54 $804M −5,805,000 −$804M
ANSS, Ansys 1.51% Exit 0 $351.22 $350M −997,128 −$350M
Holding 0.74% Exit 0 $94.58 $171M −1,810,000 −$171M
Azek 0.74% Exit 0 $54.35 $171M −3,141,400 −$171M
Championx 0.45% Exit 0 $24.84 $105M −4,245,000 −$105M
Verve Therapeutics 0.18% Exit 0 $11.23 $41M −3,612,000 −$41M
ABT, Abbott Laboratories 0.08% Exit 0 $136.01 $18M −136,000 −$18M
YMM, Full Truck Alliance 0.08% Exit 0 $11.81 $18M −1,550,598 −$18M
PARA, Paramount Global 0.07% Exit 0 $12.90 $17M −1,346,151 −$17M
Latam Airlines Group 0.06% Exit 0 $40.64 $13M −318,092 −$13M
Helix Acquisition Corporation II 0.03% Exit 0 $10.65 $6.4M −600,000 −$6.4M
VYGR, Voyager Therapeutics 0.01% Exit 0 $3.11 $2.2M −715,000 −$2.2M
Janux Therapeutics — Exit 0 $23.10 $1.1M −48,000 −$1.1M
Sage Therapeutics — Exit 0 $9.11 $390K −42,800 −$390K
UTHR, United Therapeutics — Exit 0 $287.00 $287K −1,000 −$287K
Springworks Therapeutics — Exit 0 $47.00 $235K −5,000 −$235K
Akero Therapeutics — Exit 0 $53.25 $213K −4,000 −$213K
BRKR, Bruker — Exit 0 $41.20 $206K −5,000 −$206K
Third Harmonic Bio — Exit 0 $5.40 $83K −15,361 −$83K
BYND, Beyond Meat — Exit 0 $3.47 $66K −19,000 −$66K
Biodesix — Exit 0 $0.2812 $36K −128,000 −$36K

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2025 Q2. Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top. Exit opens the last-held block below.

Filings history

20 periods, with AUM normalized

Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 89 $21.7B +23.6% 13F-HR 8/14/2026 000090883426000432
2026 Q1 1 $1.5B — new holds 8/14/2026 000090883426000434
2026 Q1 172 $17.5B −17.2% 13F-HR 5/15/2026 000090883426000240
2025 Q4 1 $1B — new holds 8/14/2026 000090883426000433
2025 Q4 2 $884M — new holds 5/15/2026 000090883426000241
2025 Q4 151 $21.2B −13.2% 13F-HR 2/17/2026 000090883426000087
2025 Q3 144 $24.4B — RESTATEMENT 2/17/2026 000090883426000086
2025 Q3 144 $24.4B +5.4% 13F-HR 11/14/2025 000090883425000353
2025 Q2 1 $140M — new holds 2/17/2026 000090883426000085
2025 Q2 3 $483M — new holds 11/14/2025 000090883425000352
2025 Q2 141 $23.2B +29.2% 13F-HR 8/14/2025 000090883425000248
2025 Q1 1 $274M — new holds 2/17/2026 000090883426000084
2025 Q1 3 $416M — new holds 11/14/2025 000090883425000351
2025 Q1 7 $2.2B — new holds 8/14/2025 000090883425000247
2025 Q1 135 $17.9B −9.0% 13F-HR 5/15/2025 000090883425000177
2024 Q4 1 $85M — new holds 2/17/2026 000090883426000083
2024 Q4 2 $349M — new holds 11/14/2025 000090883425000350
2024 Q4 6 $2.3B — new holds 8/14/2025 000090883425000246
2024 Q4 4 $333M — new holds 5/15/2025 000090883425000180
2024 Q4 138 $19.7B −3.5% 13F-HR 2/14/2025 000090883425000081
2024 Q3 1 $145M — new holds 11/14/2025 000090883425000349
2024 Q3 6 $1.5B — new holds 8/14/2025 000090883425000243
2024 Q3 3 $216M — new holds 5/15/2025 000090883425000179
2024 Q3 2 $544M — new holds 2/14/2025 000090883425000080
2024 Q3 153 $20.4B −3.6% 13F-HR 11/14/2024 000090883424000307
2024 Q2 1 $120M — new holds 11/14/2025 000090883425000348
2024 Q2 5 $1.2B — new holds 8/14/2025 000090883425000245
2024 Q2 1 $199M — new holds 5/15/2025 000090883425000178
2024 Q2 2 $452M — new holds 2/14/2025 000090883425000079
2024 Q2 1 $149M — new holds 11/14/2024 000090883424000324
2024 Q2 157 $21.2B −4.2% 13F-HR 8/14/2024 000090883424000200
2024 Q1 1 $93M — new holds 11/14/2025 000090883425000347
2024 Q1 4 $1.2B — new holds 8/14/2025 000090883425000244
2024 Q1 2 $159M — new holds 2/14/2025 000090883425000078
2024 Q1 1 $45M — new holds 8/14/2024 000090883424000202
2024 Q1 167 $22.1B — RESTATEMENT 5/24/2024 000090883424000159
2024 Q1 167 $22.1B +9.8% 13F-HR 5/15/2024 000090883424000135
2023 Q4 1 $65M — new holds 11/14/2025 000090883425000346
2023 Q4 2 $548M — new holds 8/14/2025 000090883425000250
2023 Q4 5 $1.1B — new holds 5/15/2024 000090883424000141
2023 Q4 150 $20.1B +1.0% 13F-HR 2/14/2024 000090883424000070
2023 Q3 1 $40M — new holds 11/14/2025 000090883425000345
2023 Q3 1 $40M — new holds 5/15/2024 000090883424000138
2023 Q3 2 $1.4B — new holds 2/14/2024 000090883424000077
2023 Q3 1 $1.9B — new holds 2/12/2024 000090883424000049
2023 Q3 159 $20B +11.5% 13F-HR 11/14/2023 000090883423000150
2023 Q2 2 $669M — new holds 2/14/2024 000090883424000076
2023 Q2 5 $1.4B — new holds 11/14/2023 000090883423000157
2023 Q2 1 $1.2B — new holds 10/26/2023 000090883423000134
2023 Q2 165 $17.9B +1.3% 13F-HR 8/14/2023 000090883423000109
2023 Q1 2 $234M — new holds 2/14/2024 000090883424000075
2023 Q1 3 $389M — new holds 11/14/2023 000090883423000156
2023 Q1 1 $15M — new holds 8/14/2023 000090883423000110
2023 Q1 187 $17.7B +15.8% 13F-HR 5/15/2023 000117570723000127
2022 Q4 1 $171M — new holds 2/14/2024 000090883424000074
2022 Q4 3 $485M — new holds 11/14/2023 000090883423000155
2022 Q4 7 $1B — new holds 5/15/2023 000117570723000136
2022 Q4 232 $15.3B −9.3% 13F-HR 2/14/2023 000117570723000051
2022 Q3 1 $125M — new holds 2/14/2024 000090883424000073
2022 Q3 3 $415M — new holds 11/14/2023 000090883423000154
2022 Q3 5 $411M — new holds 5/15/2023 000117570723000135
2022 Q3 4 $434M — new holds 2/14/2023 000090966123000005
2022 Q3 298 $16.8B +3.5% 13F-HR 11/14/2022 000156761922019851
2022 Q2 1 $115M — new holds 2/14/2024 000090883424000081
2022 Q2 3 $411M — new holds 11/14/2023 000090883423000153
2022 Q2 2 $337M — new holds 5/15/2023 000117570723000134
2022 Q2 3 $136M — new holds 2/14/2023 000090966123000003
2022 Q2 9 $1.2B — new holds 11/14/2022 000156761922019862
2022 Q2 297 $16.3B −13.7% 13F-HR 8/15/2022 000156761922015953
2022 Q1 1 $268M — new holds 11/14/2023 000090883423000152
2022 Q1 1 $314M — new holds 5/15/2023 000117570723000133
2022 Q1 1 $27M — new holds 2/14/2023 000090966123000002
2022 Q1 3 $186M — new holds 11/14/2022 000156761922019864
2022 Q1 8 $1.1B — new holds 8/15/2022 000156761922015972
2022 Q1 307 $18.8B +0.4% 13F-HR 5/16/2022 000156761922010736
2021 Q4 1 $227M — new holds 5/15/2023 000117570723000132
2021 Q4 1 $7M — new holds 11/14/2022 000156761922019852
2021 Q4 1 $115M — new holds 8/15/2022 000156761922015968
2021 Q4 2 $98M — new holds 5/19/2022 000156761922011257
2021 Q4 6 $833M — new holds 5/16/2022 000156761922010757
2021 Q4 289 $18.7B −5.1% 13F-HR 2/14/2022 000156761922003965
2021 Q3 1 $182M — new holds 5/15/2023 000117570723000131
2021 Q3 1 $105M — new holds 8/15/2022 000156761922015964
2021 Q3 1 $57M — new holds 5/19/2022 000156761922011256
2021 Q3 3 $998M — new holds 5/16/2022 000156761922010753
2021 Q3 2 $344M — new holds 2/14/2022 000156761922003981
2021 Q3 293 $19.7B — 13F-HR 11/15/2021 000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name
FARALLON CAPITAL MANAGEMENT, L.L.C.
Location
San Francisco, CA
All SEC filings
View on sec.gov